nl healthcare july 25 - 31, 2015

© Gyan Research and Analytics Pvt. Ltd., 2015 1

Policy News ❑ Kerala government creates registry for cancer patients The Kerala government intends to compile a registry of cancer patients to codify its initiatives against cancer. A panel of oncologists has been created which would be submitting its report in six months. Currently, there are 1.5 lakh cancer affected patients in the state, besides an annual registration of 50,000 new patients. The state has been freely distributing medicines, valued up to INR 10 crore, under different schemes.

❑ Union Government announces AIIMS-‐like facilities for J&K The Union Government has announced the setting up of an All India Institutes of Medical Science (AIIMS)-‐like facilities in Jammu & Kashmir (J&K), to bring about balanced healthcare development in the region. Such institutes would offer the same facilities as AIIMS. Further, six AIIMS will be established in six states to meet the rising demand for doctors.

❑ J&K to appoint 4,000 paramedics and 800 doctors Apart from establishing a medical college -‐ the Anantnag District Hospital in Kashmir -‐ the Union Government would be appointing more than 4,000 paramedics and 845 doctors in the next four months in J&K. The funding would be sourced followed by approval. The Anantnag District Hospital will have all manpower and logistic facilities. Further, a concept plan has been drafted to set up physiotherapy-‐cum rehabilitation, nurse training and skill development centres in the colleges.

Industry News ❑ Sun Pharma reduces staff After the acquisition of Ranbaxy for USD 3.2 billion, Sun Pharmaceuticals has decreased staff in its research and development segment. Around 150 senior executives have been retrenched, though efforts are on to retain the maximum number of employees. The acquisition was undertaken in March 2015 and has met with various challenges.

❑ India to suffer losses in pharma exports Following the ban by European Commission on 700 generic drugs, India is expected to suffer a loss of INR 6,300 crore in pharmaceutical exports, according to the Pharmaceuticals Export Promotion Council. The Ministry of Commerce intends to complain against the European Commission’s decision on account of the country’s exports of pharmaceutical products in 2014-‐15 which amounts to INR 94,275 crore.

Healthcare NewsJuly 25, 2015 – July 31, 2015


❑ Purdue University and Dr Reddy's sign MoU A Memorandum of Understanding (MoU) has been signed between Purdue University and Dr. Reddy’s to ramp up research and development. According to the agreement, a centre is to be set up at Purdue Research Park, where faculty members and students would be involved in drug innovation and development, to be followed by excellence in manufacturing. Dr. Reddy’s offers as many as 200 generics globally. The MoU will transform basic research into life-‐changing cures and therapies.

Investment News ❑ Teva Pharmaceuticals procures Allergan Teva Pharmaceuticals of Israel has purchased Allergan’s generic drugs business for USD 40.5 billion. The transaction would be both in cash and stock. Teva will pay USD 33.75 billion in cash, while the stock transaction would amount to USD 6.75 billion. Teva plans a similar agreement with Mylan. Meanwhile, Allergan plans to procure Naurex, which is manufacturing an effective antidepressant.

❑ Alivira Animal Health to acquire Lyka’s veterinary business Alivira Animal Health announced plans to purchase the veterinary business of Mumbai-‐based Lyka Labs. Alivira Animal Health is a joint venture between Shasun Pharmaceuticals and Sequent Scientific. Sequent has recently undertaken diversification of businesses. Besides exclusive patented technologies, Lyka’s animal health business would provide Sequent with an array of established products.

❑ MedPlus announces investment of INR 100 crore MedPlus plans to investment INR 100 crore to set up 350 outlets in Delhi and the National Capital Region (NCR). By the end of 2017, the number of outlets is to be raised to 400. Apart from adding 10 to 15 outlets, the firm will follow the franchise model. At present, MedPlus has more than 1,260 stores in 12 states catering to over 2 lakh consumers per day. The comapny aims to secure 25 percent share of the market.

❑ Indoco Remedies to invest INR 125 crore Indoco Remedies plans to invest INR 125 crore to expand its sterile ophthalmic facility in Goa, along with setting up a Greenfield Active Pharmaceutical Ingredient (API) facility in Maharashtra. The investment would also include an extra pilot plant in Goa for finished dosages. Funding would be from a combination of internal accruals and debt. Indoco’s domestic formulation business was 14.7 percent as of March 2015, exceeding the average of 13.3 percent.




Source: Ministry of Health and Family Welfare

Amount of Supplementary Nutrition received by Children in 2015States/UTs Children receiving food

(percent)Receiving food -‐ average

number of daysAwareness of food

entitlement (percent)Andhra Pradesh 73.7 16 86.2Assam 73.5 2 40.1Bihar 52.6 14 16.4Chhattisgarh 85.6 19 18Gujarat 86.5 19 66.5Haryana 51.9 21 14.6Himachal Pradesh 77.1 17 31.6Jammu and Kashmir 91.5 18 10.1Jharkhand 88.3 18 20.1Karnataka 80.4 21 90Kerala 75.8 20 95.1Madhya Pradesh 68.2 14 14.5Maharashtra 69.6 21 67.7Orissa 69.9 21 17.5Punjab 59.1 17 18.3Rajasthan 55.6 15 25.9Tamil Nadu 75.8 21 87.7Uttar Pradesh 40.6 14 11.5Uttrakhand 81.9 8 19.4West Bengal 78.3 21 14.5Delhi 56.4 22 14.1Chandigarh 68 22 0Arunachal Pradesh 94.4 8 0.4Manipur 44.9 12 12.6Meghalaya 79.8 18 63.6Mizoram 91.8 19 89.9Nagaland 82.4 6 93.6Tripura 77.6 17 17Sikkim 93.8 14 9.3Dadar& Nagar Haveli 60 24 92.4Daman & Diu 54.7 23 81.2Goa 73.4 20 100Puducherry 56.7 22 100Andaman & Nicobar Islands N/A 24 6.9All India 64 16 33.8

Weekly Snapshot


GYAN RESEARCH AND ANALYTICS PVT. LTD.

Corporate Office:

LG 37-‐38, Ansal Fortune Arcade, Sector -‐ 18,

Noida -‐ 201 301

Delhi NCR, INDIA

Phone: +91-‐120-‐4235181

Regd. Office:

298-‐A, Pocket 2

Mayur Vihar, Phase -‐1

Delhi -‐ 110 091, INDIA

Central Delivery Centre:

BD-‐9, Sector-‐1,

Salt Lake City

Kolkata -‐ 700 064, INDIA

Phone: +91-‐33-‐40060084

E-‐mail: [email protected]

Website: www.gyananalytics.com

Healthcare News, July 25, 2015 – July 31, 2015

OUR BUSINESS PRACTICES

Business Research

Market Entry Strategies Surveys

Pre-‐Feasibility, Feasibility & TEV Studies

Business Match Making

Economic Intelligence

Quasi Consultancy, CSR Solutions,

etc.